The apolipoprotein E ε4 allele is not a risk factor for Turkish breast cancer patients [3]

Cancer Genetics and Cytogenetics

Volumn 146, Issue 1, 2003, Pages 86-87

  Yaylim, Ilhan ^a   Bozkurt, Nilüfer ^a   Yilmaz, Hülya ^a   Isbir, Turgay ^a   Isik, Nilgün ^b   Arikan, Soykan ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Haseki Education and Training Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGE DISTRIBUTION; ALLELE; BLOOD SAMPLING; BREAST CARCINOMA; CANCER RISK; CELL PROLIFERATION; CLINICAL EXAMINATION; DNA POLYMORPHISM; ECHOGRAPHY; FAMILY HISTORY; GENE FREQUENCY; HUMAN; INFORMATION PROCESSING; LETTER; MAMMOGRAPHY; PRIORITY JOURNAL; SEX RATIO; TUMOR GROWTH; TURKEY (REPUBLIC); ADULT; AGED; BREAST TUMOR; FEMALE; GENETICS; MIDDLE AGED;

ADULT; AGED; APOLIPOPROTEINS E; BREAST NEOPLASMS; FEMALE; GENE FREQUENCY; HUMANS; MIDDLE AGED; TURKEY;

EID: 0141788531     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00124-9     Document Type: Letter

References (9)

1. Niemi M., Hakkinen T., Karttunen T.J., Eskelinen S., Kervinen K., Savollainen M.J., Lehtola J., Makela J., Yla-Herttuala S., Kesanimi Y.A. Apolipoprotein E and colon cancer. Expression in normal and malignant human intestine and effect on cultured human colonic adenocarcinoma cells. Eur J Intern Med. 13:(1):2002;37-43.
2. Miyata M., Smith J.D. Apolipoprotein E allele specific antioxidant activity and effects on cytotoxicity by oxidative insalts and betaamyloid peptides. Nat Genet. 14:1996;55-61.
3. Slooter A.J.C., Tang M.-X., van Dujin C., Stern Y., On A., Bell K., Breteler M.M.B., Broeckhoven C.V., Tatemichi T.K., Tycko B., Hoffman A., Mayeux R. Apolipoprotein E ε4 and the risk of dementia with stroke. JAMA. 277:1997;818-821.
4. Lehrer S. Possible relationship of the apolipoprotein E (ApoE) epsilon4 allele to prostate cancer. Br J Cancer. 78:1998;1398.
5. Moysich K.B., Freudenheim J.L., Baker J.A., Ambrosone C.B., Bowman E.D., Schisterman E.F., Vena J.E., Shields P.G. Apolipoprotein E genetic polymorphism, serum lipoproteins, and breast cancer risk. Mol Carcinog. 27:2000;2-9.
6. Kervinen K., Södervik H., Makela J., Lehtola J., Niemi M., Kairaluoma M.I., Kesaniemi Y.A. Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? Gastroenterology. 110:1996;1785-1790.
7. Niemi M., Kervinen K., Kiviniemi H., Lukkarinen O., Kyllönen A.-P., Sarkkinen M.A., Savolainen M.J., Kairaluoma M.I., Kesaniemi Y.A. Apolipoprotein E phenotype, cholesterol and breast and prostate cancer. J Epidemiol Commun Health. 54:2000;938-939.
8. Wessel N., Liestol K., Maehlen J., Brorson S.H. The apolipoprotein E epsilon4 allele is no risk factor for prostate cancer in the Norwegian population. Br J Cancer. 85:2001;1418.
9. Miller S.A., Dykes D.D., Polesky H.S. Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16:1988;1215-1219.